Samplix
Droplet microfluidics for functional single-cell analysis
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Samplix is a Danish biotech company headquartered in Birkerød, founded in 2013, that develops droplet microfluidics technology for high-throughput, function-first single-cell analysis. Its Xdrop platform encapsulates living cells and assay reagents in double-emulsion droplets compatible with standard flow cytometry and cell sorting, used in antibody discovery, immunotherapy and cell line development. In October 2026 it announced a EUR 25 million first close of a financing round led by WLanholding GmbH.
- Website
- samplix.com
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepagesamplix.com
For agents
Nothing listed yet.
Products
- Samplix Xdrop — Microfluidic droplet generator for single-cell workflows · Hardware